BVS - Company ID 0001665988
The table below shows Bioventus Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $30.71M | $29.46M | $35.85M | $42.16M | $32.91M | $22.80M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $138.23M | $138.41M | $120.53M | $130.40M | $132.37M | $118.08M |
| Inventory | $83.10M | $79.81M | $83.19M | $96.27M | $96.47M | $94.05M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $265.54M |
| $257.53M |
| $249.81M |
| $280.90M |
| $275.20M |
| $249.37M |
| Property, plant & equipment | - | - | - | - | - | - |
| Goodwill | $7.46M | $7.46M | $7.46M | $7.46M | $7.46M | $7.46M |
| Total assets | $673.43M | $673.35M | $650.54M | $701.59M | $706.79M | $691.41M |
| Accounts payable | $25.79M | $20.20M | $24.05M | $26.65M | $24.25M | $19.20M |
| Total current liabilities | $157.70M | $152.45M | $148.09M | $161.75M | $185.68M | $174.75M |
| Long-term debt | $211.08M | $229.70M | $253.33M | $311.33M | $297.88M | $308.59M |
| Total liabilities | $381.56M | $395.93M | $416.27M | $494.34M | $505.49M | $505.94M |
| Retained earnings | -$292.39M | -$298.38M | -$331.82M | -$349.68M | -$352.84M | -$360.30M |
| Total equity | $240.50M | $228.31M | $188.90M | $166.10M | $161.24M | $148.14M |